There is a buzz of excitement and discussion in the protein folding and design community following the publication of papers by Stephen Mayo and colleagues, describing the implementation of their new computer-assisted strategy for protein design. Address Why such interest in protein design? There are two main reasons. The first is the belief that the ultimate test of our understanding of protein structure is to design sequences that fold into the structures that we specify. The second is the hope that one day we will be able to design completely novel protein structures, possessing therapeutically or industrially important activities. Although the second reason remains a cherished goal, there has been considerable progress toward the first, and the work of Mayo and colleagues represents the latest advance in this endeavor [1, 2] . Other groups have successfully used computational approaches to calculate combinations of amino acids that are compatible with a well-packed hydrophobic core, or which will form specific ligand binding sites [3] [4] [5] [6] [7] [8] [9] [10] , but this is the first automated design of a complete peptide sequence.
How does the Mayo design strategy work? Very simply, we can break down the forces that stabilize a protein as follows: there are intrinsic differences in the propensity of each amino acid to adopt an α-helical or β-sheet conformation ( [11, 12] and references therein); superimposed upon these intrinsic propensities are additional local interactions, for example, i to i+4 interactions in an α helix and cross-strand interactions between two strands of a β sheet; loops and turns connect these elements of secondary structure; finally, and perhaps most importantly, folding a protein involves formation of a core in which the hydrophobic surface area is shielded from the aqueous environment and the buried hydrophobic residues pack together closely [13] . These components are explicitly considered in the Mayo design algorithm.
The first step in the design strategy is to choose a target fold. Then, with the backbone coordinates of this structure fixed, the program evaluates multiple randomly generated sequences, testing each amino acid sidechain in an allowed set of rotamer conformations. The allowed rotamers are derived from the distribution of sidechain rotamer conformations that are found in proteins of known structure [14] . Although these tend to cluster into only three energy minima per dihedral (-60 o , 180 o , +60 o ), even trying three combinations of every dihedral becomes a substantial computational problem, even for a relatively small protein.
One strategy that Mayo uses to avoid being overwhelmed by the combinatorial complexity of the problem is to apply the dead-end elimination theorem, in which rotamers that cannot be part of the global minimum energy conformation are identified and discarded. This approach to rotamer combination selection was originally described by Desmet and colleagues in 1992, when they applied it to model the position of the sidechains that comprise the interface of the insulin dimer, using only the backbone coordinates [15] . An additional component that goes into the Mayo scoring function is a consideration of the local and pairwise interactions in α helices and β sheets mentioned above [11, 12, 16] . Final components of the Mayo algorithm are a penalty for steric overlap and an atomic solvation parameter to favor burial and penalize exposure of hydrophobic surface area.
So, what design target to choose? The smaller the better for initial studies, but how small is the smallest stable folding unit? One would prefer a target that lacks disulfide bridges or cofactors, and there are a number of small proteins or domains of 50-60 amino acids that meet such criteria. Even 50 residues is around the upper limit for the Mayo algorithm using existing computational power. There are smaller folding units, for example, zinc-finger peptides, but these peptides, although folded in the presence of Zn, are completely unstructured in the apo-form. At first sight, therefore, a Zn finger may seem an unlikely target, save for an unexpected result obtained by Imperiali and colleagues, who synthesized a variant of a Zn finger. Their variant included two modifications from the original sequence: D-proline in a key turn position and 3-(1,10-phenanthrol-2-yl)-L-alanine as a non-natural metal chelator substituting for the natural metal ligand. Remarkably, they found that, even in the absence of metal, this 23-residue peptide is folded and by NMR studies have shown that the peptide adopts the Zn-finger fold [17] . They have, therefore, created the smallest peptide known that adopts a unique fold in the absence of either cofactors or disulfide crosslinks. With this result as precedent, it was not unreasonable to chose the 28-residue Zn finger of Zif268 as a target fold for automated design. One disadvantage of this target is that there is no sequence of exclusively natural amino acids that adopts the Zn-finger fold in the absence of Zn. Unfortunately, therefore it is not possible to test the protein's ability to identify the natural sequence as a possible solution to the design problem.
The first step in the design process was to delineate which residues are on the surface and solvent exposed, which are in the core and solvent excluded and which are intermediate or 'boundary'. An additional consideration was that two residues in the sequence have psi angles greater than zero. These residues (9 and 27) were set to be glycine to reduce backbone strain. In the natural Zif268 sequence, residue 27 is indeed a glycine, whereas residue 9 is actually a methionine, it is therefore difficult to assess the importance of these residue substitutions to the success of the design. Finally, cysteine was excluded as an allowed residue to avoid problems with unwanted disulfide bondformation; proline residues were also excluded.
The optimal sequence, which is compatible with the desired fold, was identified by running the rotamer sequence optimization program. It required 90 CPU hours on an SGI Power Challenger server with 10 R10000 processors running in parallel. The sequence obtained was named FSD-1 (Full Sequence Design-1) and it has no significant homology with naturally occurring proteins. Using FSD-1 as the starting point for a Monte Carlo simulated annealing run, generated a large family of related sequences. The sequences were all quite similar, with most variation involving surface substitutions. The amino acids comprising the core are essentially invariant. This is somewhat surprising, because other theoretical and experimental studies have shown that the natural amino acid sequence does not represent a unique solution and that there are a number, albeit small, of alternative core packing arrangements that are compatible with a stably folded protein [13, 18] . In this case, the limited sequence diversity may reflect either the small size of the core or a particular facet of the design process. With such little sequence diversity it was not surprising that the energy spread is small -about 5 kcal/mol over the top 1000 sequences.
So what to do next? As the saying goes, "The proof of the pudding is in the eating" which in this case translates to, "Make a sequence and see if the peptide folds". This is exactly what Mayo and colleagues did. They chemically synthesized FSD-1 and characterized its properties. Did it work?
The first characterization Mayo and colleagues performed was to take the circular dichroism (CD) spectrum of the peptide. The exciting result was a spectrum that is clearly indicative of a structured peptide with minima at 220 and 207 nm, which are associated with substantial β-sheet and α-helical content. CD provides a sensitive means by which to monitor the stability of the peptide to thermal denaturation. How stable is the peptide? The peptide's denaturation transition does not resemble the cooperative two-state transition that is typical for a well folded protein, but displays a broad transition with weak cooperativity, reflecting the low enthalpy associated with the folding of this small unit.
For such a small peptide, NMR studies provide an ideal means by which to assess the structure in greater detail. Does the designed structure resemble the target structure? Yes, quite well. Although not all the detailed features of the model are reproduced in the structure of the actual peptide, many key features are seen. A notable success is that the packing pattern of the hydrophobic core is similar to that of the designed structure, to the degree of detail that five of the seven residues have the designed χ 1 angles. As might be expected, many NOEs are lacking for the surface residues, which precludes a detailed analysis of their conformations.
Looking at the overall structure, starting with the C-terminal helix and working backwards, the backbone conformation of most of the helix and strand 2 up to Arg10 matches that of the target structure remarkably well (Figure 1) . The conformation of the remainder of strand 2, the turn, and strand 1 matches the design less well, with strand 1 splaying away from its β-hairpin partner, strand 2. It has been suggested that this perturbation of the structure is a result of the disruption of a hydrogen-bonding network that exists in wild-type Zif268 between the sidechain of the metal-binding residue Cys5 and the backbone amides of residues 6-8 [19] . In FSD-1, Cys5 is replaced by an alanine residue, which is unable to participate in such H-bonding interactions. The turn is therefore destabilized and the effect propagated throughout β-strand 1 (WF DeGrado, personal communication).
Like any significant result, this work raises as many questions as it answers. How many sequences in addition to FSD-1 would fold to the desired structure? I suspect quite a large number. Will their stabilities follow the computed ranking -is FSD-1 really the best? Mayo and colleagues have already synthesized a peptide in which five surface residues are changed relative to FSD-1 to be identical to the residues at these positions in Zif268; these conservative changes, together with an equally conservative buried Ile→Leu mutation are the only differences from the FSD-1 design [2] . This peptide also folds; interestingly, it is not exclusively monomeric, but forms aggregates of dimers and tetramers at high concentrations. Unwanted aggregation has been a fairly common problem with designed proteins, particularly ones containing β sheets that can associate edge on in higher order arrays [20, 21] . This result points to the fact that it is often necessary to include design features that destabilize unwanted structures -negative design -in addition to features that stabilize the desired fold [22] .
What aspects of the design algorithm are key to its success? The program incorporates a large number of components in the scoring function. How many of these are essential? Both secondary structure propensity and burial of hydrophobic surface area, for example, are explicitly included in the algorithm. It would be interesting to explore the relative contribution of each of the parameters to the program's success. It has been shown experimentally, for example, that hydrophobic patterning alone, with no explicit inclusion of secondary structure propensities, can give rise to correctly folded helical proteins [23] . Another interesting question is whether the program would be successful with a more limited alphabet? In other words, what is the minimal number of different amino acid types that need to be included to generate reasonable structures. Baker and colleagues have recently shown experimentally that an alphabet of five amino acids is sufficient to generate a folded, native-like, small α/β protein, whereas if the complexity is reduced to three amino acids this is insufficient to generate a folded protein [24] . It will be fascinating to see the results of running the Mayo algorithm with reduced amino acid libraries. In its current format, a fixed backbone is used as the design target. An additional future challenge will be to incorporate some provision to allow for backbone flexibility, which is often observed in response to changes in amino acid sequence to preserve the global fold [18] .
Finally, how generally applicable is the approach? FSD-1, at 28 amino acids, is a peptide not a protein. Mayo estimates the current upper limit for the target fold to be about 50 amino acids. Even with this size limitation, there are a number of interesting targets with different folds and several new designs are currently underway in the Mayo laboratory. He is also optimistic that with ever faster computers, the size limit for feasible design projects will soon increase; he is striving for targets of 150 amino acids within the next two years.
In summary, spectacular and tantalizing result: the protein design field awaits future developments with eager anticipation!
